ERcast: Clinical Perspectives Podcast Preview

Subscription Required

Targeted Temperature Management

Michael Kurz, MD and Matthew DeLaney, MD, FACEP, FAAEM

Sign in or Subscribe to listen.
5 starson Spotify
Sign in or Subscribe to view.Sign in or Subscribe to view.

The summary below is from an episode of ERcast: Clinical Perspectives

Targeted temperature management after out-of-hospital cardiac arrest remains a neurologic salvage strategy, not a settled dead end. TTM2 found no mortality difference between 33°C and fever prevention, but major trial populations differ from typical US arrest patients in ways that may matter at the bedside.

Targeted Temperature Management After Arrest

  • Neuroprotection signal: Hypothermia has a durable biologic rationale after cardiac arrest, with preclinical models repeatedly showing preserved brain cells and better neurologic function after cooling.
  • HACA trial benefit: The landmark HACA trial linked cooling to 32-34°C with better neurologically intact survival, improving favorable outcomes from 39% to 55% after VF arrest.
  • TTM1 misread: TTM1 showed no advantage of 33°C over 36°C, but it did not include a normothermia arm, so it never proved that active temperature control was unnecessary.
  • TTM2 neutral result: TTM2 found similar 6-month mortality with 33°C versus fever control, but hemodynamically significant arrhythmias were more common with hypothermia at 24% versus 17%.
  • Generalizability concern: TTM2 enrolled a substantially different arrest population than many US centers see, including markedly higher bystander CPR and ventricular fibrillation rates. We get into why that matters in the episode.
  • Precision over improvisation: If you use TTM, the key principle is precise core-temperature control with a closed-loop system rather than casual cooling, and there are practical transfer and measurement pearls in the chapter.

Subscribe to ERcast: Clinical Perspectives to listen to the episode.

References:

1.) Hypothermia after Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med. 2002 Feb 21;346(8):549-56. Erratum in: N Engl J Med 2002 May 30;346(22):1756. PMID: 11856793.

2.) Nielsen N, et al; TTM Trial Investigators. Targeted temperature management at 33°C versus 36°C after cardiac arrest. N Engl J Med. 2013 Dec 5;369(23):2197-206. PMID: 24237006.

3.) Dankiewicz J, et al; TTM2 Trial Investigators. Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest. N Engl J Med. 2021 Jun 17;384(24):2283-2294. PMID: 34133859.

4.) Abella BS, et al. Intra-arrest cooling improves outcomes in a murine cardiac arrest model. Circulation. 2004 Jun 8;109(22):2786-91. PMID: 15159295.

Faculty